Literature DB >> 12702907

Cardiac output determined by echocardiography in patients with cirrhosis: comparison with the indicator dilution technique.

Ulrik B Andersen1, Søren Møller, Flemming Bendtsen, Jens H Henriksen.   

Abstract

BACKGROUND/AIMS: Measurement of cardiac output in hyperkinetic patients with cirrhosis by Doppler echocardiography is increasingly reported, but has not been validated. We have compared simultaneous measurements of cardiac output by Doppler echocardiography (CO(d)) and by the indicator dilution technique (CO(I)).
METHODS: Twelve patients with cirrhosis were studied. CO(d) was measured as the spatial mean velocity of the left ventricular outflow tract, multiplied by the cross-sectional area and the heart rate. CO(I) was determined by the standard indicator dilution technique after injection of 125I albumin and 99mTc albumin into the right atrium and subsequent sampling from the femoral artery.
RESULTS: The mean CO(d) and CO(I) were similar (7.20 vs 7.15 l/min, NS). A highly significant correlation was present between CO(d) and CO(I) (r = 0.86, P < 0.0001; slope 0.91, Y(0) = 0.78 l/min). However, the mean squared difference between CO(d) and CO(I) was 2.3 (l/min)2. A Bland-Altman plot revealed no trend with the level of cardiac output. The standard deviation (0.79 vs 0.30 l/min, P < 0.01) and the coefficient of variation (10.5 vs 4.2%, P < 0.01) of duplicate measurements were significantly higher with the Doppler technique.
CONCLUSION: Doppler measurements of cardiac output in groups of patients with cirrhosis are accurate with respect to the group mean, but marked disagreements of over- and underestimation were seen in individual patients. The reproducibility of the Doppler technique is acceptable, although not as good as that of the indicator dilution technique.

Entities:  

Mesh:

Year:  2003        PMID: 12702907     DOI: 10.1097/01.meg.0000059106.41030.8e

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

2.  Estimation of cardiac output in a pharmacological trial using a simple method based on arterial blood pressure signal waveform: a comparison with pulmonary thermodilution and echocardiographic methods.

Authors:  Jani Penttilä; Amir Snapir; Erkki Kentala; Juha Koskenvuo; Jussi Posti; Mika Scheinin; Harry Scheinin; Tom Kuusela
Journal:  Eur J Clin Pharmacol       Date:  2006-03-29       Impact factor: 2.953

Review 3.  Recent advances in cirrhotic cardiomyopathy.

Authors:  Dimitrios S Karagiannakis; George Papatheodoridis; Jiannis Vlachogiannakos
Journal:  Dig Dis Sci       Date:  2014-11-18       Impact factor: 3.199

4.  Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease.

Authors:  Alexander C Egbe; Heidi M Connolly; William R Miranda; Naser M Ammash; Donald J Hagler; Gruschen R Veldtman; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2017-12       Impact factor: 8.790

5.  The end-organ impairment in liver cirrhosis: appointments for critical care.

Authors:  Antonio Figueiredo; Francisco Romero-Bermejo; Rui Perdigoto; Paulo Marcelino
Journal:  Crit Care Res Pract       Date:  2012-05-16

6.  In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival.

Authors:  Chien-Hao Huang; Lung-Sheng Wu; Wen-Juei Jeng; Yu-Fu Cheng; Yu-Shien Ko; I-Shyan Sheen; Chun-Yen Lin
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.